Mark S. Graham

Array ( [id] => 5976011 [patent_doc_number] => 20110070269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'LIPOPOLYSACCHARIDE ISOLATED FROM PYRULARIA TISSUE AND/OR PYRULARIA-ASSOCIATED BACTERIA AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/890502 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18102 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070269.pdf [firstpage_image] =>[orig_patent_app_number] => 12890502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9073898 [patent_doc_number] => 08551474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase' [patent_app_type] => utility [patent_app_number] => 12/890178 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 38 [patent_no_of_words] => 22318 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12890178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929320 [patent_doc_number] => 20110039279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSING BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/888214 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13935 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039279.pdf [firstpage_image] =>[orig_patent_app_number] => 12888214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038427 [patent_doc_number] => 20110091476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/880961 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35562 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091476.pdf [firstpage_image] =>[orig_patent_app_number] => 12880961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10130268 [patent_doc_number] => 09164098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Determining an expression status of human epidermal growth factor receptor 2 (HER2) in a biological sample' [patent_app_type] => utility [patent_app_number] => 12/879619 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 6433 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12879619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484610 [patent_doc_number] => 20110250233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)-GALACTOSYLTRANSFERASE' [patent_app_type] => utility [patent_app_number] => 12/878756 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 21477 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250233.pdf [firstpage_image] =>[orig_patent_app_number] => 12878756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483708 [patent_doc_number] => 20120283115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'SEROMIC ANALYSIS OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/392919 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21580 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10529003 [patent_doc_number] => 09255131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Identification of surface-associated antigens for tumor diagnosis and therapy' [patent_app_type] => utility [patent_app_number] => 12/851980 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 66 [patent_no_of_words] => 31476 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12851980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10014095 [patent_doc_number] => 09057106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-16 [patent_title] => 'Method of determination of diagnosis and prognosis in patients with B-cell chronic lymphocytic leukemia and oligonucleotides for use in this method' [patent_app_type] => utility [patent_app_number] => 13/388438 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8130 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439308 [patent_doc_number] => 20100279323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'METHOD FOR PREDICTING RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR-DIRECTED THERAPY' [patent_app_type] => utility [patent_app_number] => 12/826386 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6610 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279323.pdf [firstpage_image] =>[orig_patent_app_number] => 12826386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6264882 [patent_doc_number] => 20100297653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'METHODS OF DIAGNOSING AND TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/789884 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17452 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297653.pdf [firstpage_image] =>[orig_patent_app_number] => 12789884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262722 [patent_doc_number] => 20100297136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Gastric and Prostate Cancer Associated Antigens' [patent_app_type] => utility [patent_app_number] => 12/764333 [patent_app_country] => US [patent_app_date] => 2010-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10965 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297136.pdf [firstpage_image] =>[orig_patent_app_number] => 12764333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432721 [patent_doc_number] => 20100278727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Alpha-Emitting constructs and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/799186 [patent_app_country] => US [patent_app_date] => 2010-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12932 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278727.pdf [firstpage_image] =>[orig_patent_app_number] => 12799186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9581694 [patent_doc_number] => 08771695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Antibodies directed to HER-3 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/761370 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 33 [patent_no_of_words] => 26962 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12761370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270766 [patent_doc_number] => 20100254989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Bispecific Anti ErbB1 / Anti c Met Antibodies' [patent_app_type] => utility [patent_app_number] => 12/753145 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26922 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254989.pdf [firstpage_image] =>[orig_patent_app_number] => 12753145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270762 [patent_doc_number] => 20100254988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Bispecific Anti ErbB2 / Anti cMet Antibodies' [patent_app_type] => utility [patent_app_number] => 12/753141 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26821 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254988.pdf [firstpage_image] =>[orig_patent_app_number] => 12753141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276889 [patent_doc_number] => 20100256339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Bispecific Anti ErbB3 / Anti cMet Antibodies' [patent_app_type] => utility [patent_app_number] => 12/752196 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 31286 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256339.pdf [firstpage_image] =>[orig_patent_app_number] => 12752196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228810 [patent_doc_number] => 20100183548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'TWEAK RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/751912 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19524 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183548.pdf [firstpage_image] =>[orig_patent_app_number] => 12751912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339985 [patent_doc_number] => 20100247533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'TREATMENT WITH A HUMANIZED ANTI-EGFR IgG1 ANTIBODY AND IRINOTECAN' [patent_app_type] => utility [patent_app_number] => 12/748506 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15556 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247533.pdf [firstpage_image] =>[orig_patent_app_number] => 12748506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195537 [patent_doc_number] => 20110027291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/707521 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 40355 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027291.pdf [firstpage_image] =>[orig_patent_app_number] => 12707521 [rel_patent_id] =>[rel_patent_doc_number] =>)